Update on ECMO for COVID-19 Weaning - V-A ECMO with Cardiogenic Shock Recombinant Activ. Factor VII скачать в хорошем качестве

Update on ECMO for COVID-19 Weaning - V-A ECMO with Cardiogenic Shock Recombinant Activ. Factor VII

Vanderbilt University Medical Center; Department of CV Surgery: Faculty Forum Update on ECMO for COVID-19: What have we learned? Faculty: J. Hoffman, MD, Matt Warhoover, CCP, A. Lepore, CCP Tammy Sparacino Journal Club: Early experience of pump-controlled retrograde trial off for weaning from veno-arterial extracorporeal membrane oxygenation (VA ECMO) in adult patients with cardiogenic shock. Pump-controlled retrograde trial off has recently been introduced as an effective method for weaning from veno-arterial extracorporeal membrane oxygenation in pediatric patients. However, studies on pump-controlled retrograde trial off in adults are still lacking. Thus, this study aimed to examine the outcomes of pump-controlled retrograde trial off for weaning from veno-arterial extracorporeal membrane oxygenation in adult patients. John Ingram Knowledge Nuggets: Recombinant Activated Human Factor VII Register and watch for free @ https://library.perfusioneducation.com Get our Perfusion App - https://perfusioneducation.com/perfus... IV Dosage and Rate Calculator - https://mediweb.us/iv-medication-calc... Subscribe to our podcast: Apple Podcasts - https://podcasts.apple.com/us/podcast... Google Podcasts - https://www.google.com/podcasts?feed=... Spotify - https://open.spotify.com/show/7FWOk2u... Visit our websites: https://mediweb.us https://perfweb.us https://perfusioneducation.com See Our Schedule: https://perfweb.us/webinar-schedule/